Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisuke Mori

Showing results (171-180 of 270) with videos related to

Pageof 27
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 16, 2020
Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology GroupSatoshi Takeuchi, Haruo Kuroboshi, Taisuke Mori, et al.
Histopathology|January 29, 2020
Mesenchymal tumours with RREB1-MRTFB fusion involving the mediastinum: extra-glossal ectomesenchymal chondromyxoid tumours?Naohiro Makise, Taisuke Mori, Hiroshi Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancerNorimasa Koide, Taketo Yamada, Rie Shibata, et al.
The Journal of Obstetrics and Gynaecology Research|December 22, 2018
Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201)Taisuke Mori, Hiroshi Makino, Tomoharu Okubo, et al.
Anticancer Research|January 31, 2021
BP180 Is a Prognostic Factor in Head and Neck Squamous Cell CarcinomaXue Meng, Fumihiko Matsumoto, Taisuke Mori, et al.
Journal of Radiation Research|September 23, 2022
Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinomaYusaku Miyata, Naoya Murakami, Yoshitaka Honma, et al.
Histopathology|February 8, 2023
Keratin-positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumourHirokazu Sugino, Shintaro Iwata, Kaishi Satomi, et al.
Diagnostic Pathology|January 15, 2025
TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumorsYuka Takahashi, Akihiko Yoshida, Seiichi Yoshimoto, et al.
Reproduction (Cambridge, England)|July 6, 2026
PGRMC1 suppression enhances progesterone responsiveness in stromal cells of ovarian endometriomaYuko Izumi, Yosuke Tarumi, Kota Aoki, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|July 28, 2020
Atherosclerosis-related biomarkers in women with endometriosis: The effects of dienogest and oral contraceptive therapyEiko Maeda, Akemi Koshiba, Taisuke Mori, et al.
Pageof 27

Showing results (171-180 of 270) with videos related to

Sort By:
Pageof 27
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 16, 2020
Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology GroupSatoshi Takeuchi, Haruo Kuroboshi, Taisuke Mori, et al.
Histopathology|January 29, 2020
Mesenchymal tumours with RREB1-MRTFB fusion involving the mediastinum: extra-glossal ectomesenchymal chondromyxoid tumours?Naohiro Makise, Taisuke Mori, Hiroshi Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancerNorimasa Koide, Taketo Yamada, Rie Shibata, et al.
The Journal of Obstetrics and Gynaecology Research|December 22, 2018
Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201)Taisuke Mori, Hiroshi Makino, Tomoharu Okubo, et al.
Anticancer Research|January 31, 2021
BP180 Is a Prognostic Factor in Head and Neck Squamous Cell CarcinomaXue Meng, Fumihiko Matsumoto, Taisuke Mori, et al.
Journal of Radiation Research|September 23, 2022
Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinomaYusaku Miyata, Naoya Murakami, Yoshitaka Honma, et al.
Histopathology|February 8, 2023
Keratin-positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumourHirokazu Sugino, Shintaro Iwata, Kaishi Satomi, et al.
Diagnostic Pathology|January 15, 2025
TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumorsYuka Takahashi, Akihiko Yoshida, Seiichi Yoshimoto, et al.
Reproduction (Cambridge, England)|July 6, 2026
PGRMC1 suppression enhances progesterone responsiveness in stromal cells of ovarian endometriomaYuko Izumi, Yosuke Tarumi, Kota Aoki, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|July 28, 2020
Atherosclerosis-related biomarkers in women with endometriosis: The effects of dienogest and oral contraceptive therapyEiko Maeda, Akemi Koshiba, Taisuke Mori, et al.
Pageof 27